精密科学(EXAS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EXAS 精密科学

未开盘 11-21 16:00:00 EST

53.07

+0.37

+0.70%

盘后53.50

+0.43+0.81%

19:39 EST

最高54.06	最低52.17	成交量257.85万
今开52.77	昨收52.70	日振幅3.59%
总市值98.22亿	流通市值97.50亿	总股本1.85亿
成交额1.38亿	换手率1.40%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EXAS","market":"US","secType":"STK","nameCN":"精密科学","latestPrice":53.07,"timestamp":1732222800000,"preClose":52.7,"halted":0,"volume":2578515,"hourTrading":{"tag":"盘后","latestPrice":53.5,"preClose":53.07,"latestTime":"19:39 EST","volume":207520,"amount":11013091.76,"timestamp":1732235976643},"delay":0,"floatShares":183724662,"shares":185076293,"eps":-1.168658,"marketStatus":"未开盘","marketStatusCode":0,"change":0.37,"latestTime":"11-21 16:00:00 EST","open":52.77,"high":54.06,"low":52.17,"amount":137771002.765005,"amplitude":0.035863,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.168658,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":980917200000,"adjPreClose":52.7,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":52.67,"preClose":52.7,"latestTime":"09:29 EST","volume":522,"amount":27553.445315999998,"timestamp":1732199399999},"postHourTrading":{"tag":"盘后","latestPrice":53.5,"preClose":53.07,"latestTime":"19:39 EST","volume":207520,"amount":11013091.76,"timestamp":1732235976643},"volumeRatio":0.98364,"impliedVol":0.4516,"impliedVolPercentile":0.0476},"requestUrl":"/m/hq/s/EXAS/tweets","defaultTab":"tweets","newsList":[{"id":"2484920017","title":"精密科学盘中异动 急速拉升5.03%报52.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920017?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:57","pubTimestamp":1732035449,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时57分，精密科学股票出现波动，股价大幅拉升5.03%。截至发稿，该股报52.03美元/股，成交量74.0341万股，换手率0.40%，振幅5.49%。机构评级方面，在所有23家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。精密科学股票所在的生命科学行业中，整体涨幅为0.33%。精密科学的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000572998e438ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000572998e438ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","EXAS","LU1861559042.SGD","BK4585","BK4139","BK4548","LU1861558580.USD","LU0266013472.USD"],"gpt_icon":0},{"id":"2482084245","title":"精密科学盘中异动 大幅下跌5.16%报48.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482084245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482084245?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:20","pubTimestamp":1731424840,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时20分，精密科学股票出现异动，股价快速下挫5.16%。截至发稿，该股报48.68美元/股，成交量75.829万股，换手率0.41%，振幅3.72%。机构评级方面，在所有24家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。精密科学股票所在的生命科学行业中，整体涨幅为0.08%。精密科学的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223204098e421ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223204098e421ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861558580.USD","BK4585","LU1861559042.SGD","BK4139","BK4548","LU0266013472.USD","EXAS"],"gpt_icon":0},{"id":"2482201282","title":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2482201282","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482201282?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:08","pubTimestamp":1731308918,"startTime":"0","endTime":"0","summary":"美国研究综述-Akamai Technologies、Bill Holdings、Veeva Systems路透11月11日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Akamai Technologies、Bill Holdings 和 Veeva Systems。要闻  * Akamai Technologies Inc AKAM.O：汇丰银行将目标价从107美元上调至121美元 * Bill Holdings Inc BILL.N：杰富瑞将目标价从65美元上调至92美元 * Charles River Laboratories International CRL.N：TD Cowen将目标价从203美元上调至227美元 * Veeva Systems Inc VEEV.N：Jefferies 将目标价从 240 美元上调至 280 美元 * Xeris Biopharma Holdings Inc XERS.O：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4S3MI0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXAS","CACI","DOCS","AFL","EXR","CIM","LU0690374615.EUR","CUZ","APA","BHF","BK4565","BK4528","CNA","ACT","ALRM","DKNG","COTY","EVH","CYBR","BAX","BOW","BRX","CTKB","BK4077","BK4167","BILL","BMBL","AKAM","ADPT","AMP","CERT","LU2552382215.SGD","LU0511384066.AUD","CPAY","CRL","CRBG","CUBE","CBT","ATMU","ANIP","ENPH","BK4539","EL","TKNO","CELH","BK4530","VEEV","CRK"],"gpt_icon":1},{"id":"2482262049","title":"精密科学2024财年第三财季实现净利润-38.24百万美元，同比减少4916.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482262049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482262049?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254506,"startTime":"0","endTime":"0","summary":"11月11日，精密科学公布财报，公告显示公司2024财年第三财季净利润为-38.24百万美元，同比减少4916.12%；其中营业收入为7.09亿美元，同比增加12.90%，每股基本收益为-0.21美元。机构评级：截至2024年11月11日，当前有21家机构对精密科学目标价做出预测，其中目标均价为71.19美元，其中最低目标价为60.00美元，最高目标价为85.00美元。精密科学的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000231a229e489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000231a229e489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EXAS"],"gpt_icon":0},{"id":"1154925832","title":"异动解读 | 精密科学公司大幅下调收入预期 股价盘中重挫近30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154925832","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154925832?lang=zh_cn&edition=full","pubTime":"2024-11-07 05:40","pubTimestamp":1730929243,"startTime":"0","endTime":"0","summary":"11月6日,癌症检测制造商精密科学公司盘中股价大跌近30%,引发市场广泛关注。这一重挫和公司发布的糟糕财报数据以及下调的收入指引不无关系。具体来看,精密科学公司公布的2024财年第三季度营收实际达到7.09亿美元,低于市场预期的7.177亿美元。上述收入预期的大幅下调引发了市场对公司未来收入增长前景的担忧,成为股价重挫的主因。在业绩承压的背景下,精密科学的股价遭遇了重挫。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"2481934099","title":"BUZZ-Exact Sciences 下调全年收入预期，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481934099","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481934099?lang=zh_cn&edition=full","pubTime":"2024-11-07 02:42","pubTimestamp":1730918574,"startTime":"0","endTime":"0","summary":"BUZZ-Exact Sciences 下调全年收入预期，业绩下滑11月6日 -  ** 癌症测试制造商Exact SciencesEXAS.O股价下跌24.9%，报53.72美元 ** 周二收盘后，公司下调了2024年总收入和筛查收入预期 ** 公司目前的营收预期在27.3亿美元到27.5亿美元之间，而之前的预期为28.1亿美元到28.5亿美元之间 ** 飓风 \"是第三季度至第四季度收入连续下降的最大原因。** 公司目前预计 2024 年的筛查收入将在 20.8 亿至 21.0 亿美元之间，而之前的预测为 21.6 亿至 21.8 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD32S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","EXAS","BK4139","LU0266013472.USD","LU1861558580.USD","BK4588","LU1861559042.SGD","BK4585"],"gpt_icon":0},{"id":"1102647847","title":"异动解读 | 精密科学公司财报疲软收入指引下调 股价重挫近28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102647847","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102647847?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:47","pubTimestamp":1730904424,"startTime":"0","endTime":"0","summary":"11月6日,癌症检测公司精密科学公司盘中大跌近28%,引发市场广泛关注。根据公司公布的2024财年第三季度财报,营收实际达7.09亿美元,低于市场预期的7.177亿美元。更为重要的是,公司下调了2024年全年收入指引,将全年收入预期从之前的28.1亿美元至28.5亿美元,下调至27.3亿美元至27.5亿美元。同时,该公司还将旗下核心业务筛选部门的收入指引从之前的21.6亿美元至21.8亿美元,下调至20.8亿美元至21亿美元。在业绩承压的背景下,精密科学的股价遭遇了重创。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"2481406986","title":"精密科学股价重挫22.76% 市值跌23.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481406986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481406986?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903598,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时33分，精密科学股票出现波动，股价急速跳水22.76%。截至发稿，该股报55.24美元/股，成交量153.639万股，换手率0.83%，振幅2.36%。精密科学股票所在的生命科学行业中，整体涨幅为0.33%。精密科学的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622331895bddb9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622331895bddb9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0266013472.USD","BK4548","LU1861558580.USD","EXAS","BK4585","LU1861559042.SGD","BK4139"],"gpt_icon":0},{"id":"2481624519","title":"美国研究综述-阿波罗、Booking Holdings、Portillos","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624519?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:15","pubTimestamp":1730884501,"startTime":"0","endTime":"0","summary":"    路透11月6日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、Booking Holdings 和 Portillos。要闻 * 阿波罗  ：摩根大通将目标价从143美元上调至161美元 * Aris Water Solutions Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Booking Holdings Inc   ：Truist Securities将目标价从4100美元上调至4700美元  * Choice Hotels International Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Portillos Inc   ：Stifel将其评级从 \"买入 \"下调至 \"持有  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","AHCO","EMR","CTRE","ABNB","AIG","ADUS","CC","ANAB","BK4113","LU0708994859.HKD","LU2065169927.USD","AVB","ACLX","LU0029874061.USD","LU0426417589.USD","MO","BR","ABBV","AMH","ALL","BKNG","GO","BEAM","HPK","BK4141","DBRG","IT","AGCO","EMN","BLDR","BRKR","EXAS","FRPT","GFS","GXO","CHH","GMED","APO","ARIS","FIS","AZPN","BVS","BOW","CE","CMI","INZY","APLS","LU0868494708.USD","LU0390134368.USD"],"gpt_icon":0},{"id":"1114644491","title":"异动解读 | 精密科学公司下调收入预期 股价重挫27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114644491","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114644491?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:12","pubTimestamp":1730884333,"startTime":"0","endTime":"0","summary":"癌症测试制造商精密科学公司周一盘后大幅下挫27.13%,报收52美元,引发市场广泛关注。此前公司公布的2024财年第三季度财报数据低于预期,并下调了2024年全年收入指引,成为引发本轮股价重挫的主要原因。同时,该公司还将旗下核心业务筛选部门的收入指引从之前的21.6亿美元至21.8亿美元,下调至20.8亿美元至21亿美元。在业绩承压的背景下,精密科学的股价遭遇了重创。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"1139080802","title":"异动解读 | 精密科学公司下调收入预期 股价盘后重挫逾30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139080802","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139080802?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:10","pubTimestamp":1730880642,"startTime":"0","endTime":"0","summary":"精密科学公司周一盘后大跌30.07%,收于52美元,引发市场关注。同时,精密科学下调了2024年全年收入指引,将全年营收预期从之前的28.1亿美元至28.5亿美元,下调至27.3亿美元至27.5亿美元,筛选部门的收入指引也从之前的21.6亿美元至21.8亿美元,下调至20.8亿美元至21亿美元。收入预期的大幅下调引发了市场对公司未来收入增长前景的担忧,成为股价重挫的主因。在业绩承压的背景下,精密科学的股价遭遇了重创。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"1157637050","title":"异动解读 | 精密科学下调收入预期 股价大跌逾29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157637050","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157637050?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:06","pubTimestamp":1730855210,"startTime":"0","endTime":"0","summary":"精密科学公司(EXAS)周一盘后大跌29.93%,原因是公司下调了2024年全年收入预期。\n\n具体而言,精密科学将2024年全年收入预期从之前的28.1亿美元至28.5亿美元,下调至27.3亿美元至27.5亿美元。公司还将旗下筛选部门的收入指引从之前的21.6亿美元至21.8亿美元,下调至20.8亿美元至21亿美元。\n\n另外,公司第三季度实际营收7.09亿美元,低于之前预期的7.177亿美元。尽管公司表示计划在2025年加速增长,长期前景依旧强劲,但收入预期的下调令市场对公司未来收入增长前景感到担忧,从而引发了这一股价大跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"1158406056","title":"异动解读 | 精密科学盘后大跌28% 业绩低预期引发收入增长担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1158406056","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158406056?lang=zh_cn&edition=full","pubTime":"2024-11-06 05:40","pubTimestamp":1730842845,"startTime":"0","endTime":"0","summary":"据路透报道,癌症测试制造商精密科学公司(EXAS)周一盘后重挫28.16%,收于52美元。公司下调2024年全年收入指引,引发市场对其未来收入增长前景的担忧。\n\n精密科学公司将2024年全年收入预期从之前的28.1亿美元至28.5亿美元,下调至27.3亿美元至27.5亿美元。公司还将筛选部门的收入指引从之前的21.6亿美元至21.8亿美元,下调至20.8亿美元至21亿美元。\n\n公司表示,第三季度实际营收7.09亿美元,低于预期的7.177亿美元。公司CEO表示,\"我们在第三季度的执行情况和更新的全年展望没有反映出我们的全部潜力。\"但他强调公司计划在2025年加速增长,长期前景依旧强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["EXAS"],"gpt_icon":0},{"id":"2481887654","title":"BUZZ-埃杰特科学公司下调 2024 年收入预期后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2481887654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481887654?lang=zh_cn&edition=full","pubTime":"2024-11-06 05:37","pubTimestamp":1730842631,"startTime":"0","endTime":"0","summary":"** 将筛选部门的收入指导从之前的 21.6 亿至 21.8 亿美元下调至 20.8 亿至 21 亿美元** 我们在第三季度的执行情况和更新的全年展望没有反映出我们的全部潜力。我们计划在 2025 年加速增长，我们的长期前景依然强劲。** 截至上次收盘，公司股价累计下跌 3.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","BK4588","LU1861558580.USD","EXAS","LU0266013472.USD","BK4139","LU1861559042.SGD"],"gpt_icon":0},{"id":"2479444458","title":"美国研究综述-Coinbase Global、Meta、联合太平洋公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2479444458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479444458?lang=zh_cn&edition=full","pubTime":"2024-10-29 14:41","pubTimestamp":1730184072,"startTime":"0","endTime":"0","summary":"    路透10月29日 - 华尔街证券分析师周二调整了对 Coinbase Global、Meta 和联合太平洋等几家美国上市公司的评级和目标价。要点             * Coinbase Global Inc   ：摩根大通将目标价从181美元上调至196美元             * Meta   ：Wedbush将目标价从600美元上调至640美元             * Union Pacific Corp   ：大和资本市场将目标价从250美元下调至240美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4624e84750d72ade2ebcb09583409b58","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGA","NARI","IE00B7KXQ091.USD","CCB","CX","IE0034235303.USD","TREX","LU2552382215.SGD","NTRA","UNP","BK4086","NCLH","FFIV","LU0068578508.USD","VFC","WST","BK4121","LU2756315664.SGD","IE0005OL40V9.USD","LU0203345920.USD","HON","BK4090","BK4202","EXAS","EL","IE00BQXX3D17.EUR","BK4142","CSTL","IE00B1BXHZ80.USD","META","RCL","COIN","SBAC","LU1861219969.SGD","LU0061475181.USD","TMDX","BK4507","BK4585","BK4588","SARO","OLN","LU2065171402.SGD","DAN","LU0266013472.USD","LU0390134368.USD","LU2065171311.SGD","MHK","LU0198837287.USD","IE00BK4W5M84.HKD","AMKR"],"gpt_icon":1},{"id":"2472587359","title":"BUZZ-美国食品和药物管理局（FDA）批准新型结肠直肠癌检测，Exact Sciences公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2472587359","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472587359?lang=zh_cn&edition=full","pubTime":"2024-10-04 19:38","pubTimestamp":1728041927,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月4日 - ** 癌症测试制造商Exact Sciences   的股价盘前上涨1.2%至67.22美元** 该公司称，美国食品和药物管理局（FDA）批准了 (link) 其名为 \"Cologuard Plus \"的粪便 DNA 检测，用于筛查结肠直肠癌。** EXAS称，新检测方法可减少假阳性筛查的可能性，从而最大限度地减少不必要的后续结肠镜检查。** 大肠癌发生在结肠或直肠，它们是大肠的一部分** 截至上一交易日收盘，股价累计下跌 10.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","EXAS","LU1861558580.USD","BK4139","BK4588","BK4585","LU1861559042.SGD","LU0266013472.USD"],"gpt_icon":0},{"id":"2467145758","title":"精密科学(EXAS)盘前升8.88% 公司结直肠癌筛查新技术表现优异","url":"https://stock-news.laohu8.com/highlight/detail?id=2467145758","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467145758?lang=zh_cn&edition=full","pubTime":"2024-09-16 19:52","pubTimestamp":1726487559,"startTime":"0","endTime":"0","summary":"金吾财讯 | 精密科学 盘前走高，暂升8.88%，报71.36美元。消息面上，公司今天公布了其血液检测的结直肠癌筛查测试的性能数据。结果显示，对于结直肠癌的敏感性为88.3%，对于高级癌前病变的敏感性为31.2%，在阴性样本通过结肠镜检查确认的特异性为90.1%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MTI5MjQwNzE0NzY0NzE5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTI5MjQwNzE0NzY0NzE5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","LU1861559042.SGD","LU0266013472.USD","BK4585","BK4548","LU1861558580.USD","EXAS"],"gpt_icon":0},{"id":"2467389117","title":"精密科学盘中异动 下午盘大幅拉升5.05%报67.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467389117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467389117?lang=zh_cn&edition=full","pubTime":"2024-09-13 03:14","pubTimestamp":1726168467,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日03时14分，精密科学股票出现异动，股价急速上涨5.05%。截至发稿，该股报67.36美元/股，成交量380.327万股，换手率2.06%，振幅5.10%。精密科学股票所在的生命科学行业中，整体跌幅为0.51%。Exact的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。消息层面，截至03时14分，精密科学股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409130314279719b2a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409130314279719b2a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1861558580.USD","LU1861559042.SGD","LU0266013472.USD","BK4548","BK4585","EXAS","BK4588"],"gpt_icon":0},{"id":"2457779042","title":"精密科学盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457779042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457779042?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:17","pubTimestamp":1722867437,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日22时17分，精密科学股票出现波动，股价大幅下跌5.04%。截至发稿，该股报54.46美元/股，成交量44.1911万股，换手率0.24%，振幅5.04%。精密科学股票所在的生命科学行业中，整体跌幅为3.05%。Exact的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522171796823fac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080522171796823fac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU1861558580.USD","BK4585","LU0266013472.USD","LU1861559042.SGD","BK4548","BK4139","EXAS"],"gpt_icon":0},{"id":"2457775874","title":"精密科学2024财年第二财季实现净利润-15.81百万美元，同比增加80.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775874","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775874?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:17","pubTimestamp":1722788261,"startTime":"0","endTime":"0","summary":"8月5日，精密科学公布财报，公告显示公司2024财年第二财季净利润为-15.81百万美元，同比增加80.49%；其中营业收入为6.99亿美元，同比增加12.38%，每股基本收益为-0.09美元。机构评级：截至2024年8月5日，当前有21家机构对精密科学目标价做出预测，其中目标均价为76.29美元，其中最低目标价为60.00美元，最高目标价为100.00美元。Exact的Cologuard筛查测试是一种基于粪便的无创DNA测试，是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001748957caaba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001748957caaba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EXAS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exactsciences.com","stockEarnings":[{"period":"1week","weight":0.042},{"period":"1month","weight":-0.2481},{"period":"3month","weight":-0.1111},{"period":"6month","weight":0.0648},{"period":"1year","weight":-0.1883},{"period":"ytd","weight":-0.2826}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Exact Sciences Corporation是一家分子诊断公司，专注大肠癌的早期检测和预防。公司于1995年2月10日在特拉华州合并，拥有无创分子检测技术的自主知识产权，可检测大肠癌癌前病变和大肠癌。公司目标是成为关爱病人的诊断筛查产品的市场领军企业，生产用于大肠癌癌前病变和大肠癌早期检测的产品。为实现此目标，公司制定的战略路线包括以下几个要点：研发产品，通过美国食品药品管理局（FDA）的临床批准手续；使FDA批准的产品商业化，检测大肠癌癌前病变和大肠癌；从产品支付人那拿到可观的产品补偿。","yearOnYearQuotes":[{"month":1,"riseRate":0.521739,"avgChangeRate":0.094051},{"month":2,"riseRate":0.291667,"avgChangeRate":-0.062334},{"month":3,"riseRate":0.583333,"avgChangeRate":0.076896},{"month":4,"riseRate":0.416667,"avgChangeRate":0.01784},{"month":5,"riseRate":0.541667,"avgChangeRate":0.055726},{"month":6,"riseRate":0.625,"avgChangeRate":0.093567},{"month":7,"riseRate":0.375,"avgChangeRate":-0.013807},{"month":8,"riseRate":0.416667,"avgChangeRate":0.011798},{"month":9,"riseRate":0.5,"avgChangeRate":-0.002091},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.04237},{"month":11,"riseRate":0.583333,"avgChangeRate":0.010766},{"month":12,"riseRate":0.608696,"avgChangeRate":0.06302}],"exchange":"NASDAQ","name":"精密科学","nameEN":"Exact Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精密科学(EXAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精密科学(EXAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精密科学,EXAS,精密科学股票,精密科学股票老虎,精密科学股票老虎国际,精密科学行情,精密科学股票行情,精密科学股价,精密科学股市,精密科学股票价格,精密科学股票交易,精密科学股票购买,精密科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精密科学(EXAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精密科学(EXAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}